leflunomide has been researched along with ps1145 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Kanoh, S; Kubo, K; Rubin, BK; Tanabe, T; Tsushima, K; Yamazaki, Y | 1 |
2 other study(ies) available for leflunomide and ps1145
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Clarithromycin inhibits interleukin-13-induced goblet cell hyperplasia in human airway cells.
Topics: Bronchi; Cell Differentiation; Clarithromycin; Enzyme Inhibitors; ErbB Receptors; Flavonoids; Goblet Cells; Heterocyclic Compounds, 3-Ring; Humans; Hyperplasia; Interleukin-13; Isoxazoles; Janus Kinases; Leflunomide; MAP Kinase Signaling System; Mucin 5AC; Mucus; NF-kappa B; Protein Synthesis Inhibitors; Pyridines; Respiratory Mucosa; Signal Transduction; STAT6 Transcription Factor | 2011 |